Aigen Investment Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$466K Buy
+3,104
New +$338K 0.13% 210
2026
Q1
Sell
-2,105
Closed -$215K 628
2025
Q4
$215K Buy
+2,105
New +$188K 0.05% 462
2025
Q2
Sell
-28,298
Closed -$1.21M 894
2025
Q1
$1.21M Buy
28,298
+2,341
+9% +$101K 0.19% 161
2024
Q4
$793K Buy
25,957
+6,854
+36% +$193K 0.14% 216
2024
Q3
$438K Buy
19,103
+3,683
+24% +$104K 0.09% 358
2024
Q2
$445K Buy
+15,420
New +$359K 0.09% 344
2022
Q1
Sell
-7,378
Closed -$701K 742
2021
Q4
$701K Buy
+7,378
New +$763K 0.04% 524
2020
Q2
Sell
-2,950
Closed -$205K 981
2020
Q1
$205K Buy
+2,950
New +$226K 0.03% 700

Other funds holding GH

Aigen Investment Management's GH Position: Q2 2026 in Review

Aigen Investment Management opened a new position in Guardant Health (GH) in Q2 2026: 3,104 shares worth $466K. The stake represents 0.13% of the portfolio and ranks #210 among its holdings. This is a return to the name: Aigen Investment Management previously reported a position in GH as recently as Q4 2025.

Aigen Investment Management first reported a position in GH in Q1 2020 and has held it in 8 quarters since. The position peaked at $1.21M in Q1 2025. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Aigen Investment Management held 3,104 shares of Guardant Health worth $466K as of Q2 2026.
  • Guardant Health was a new Aigen Investment Management position in Q2 2026.
  • Guardant Health made up 0.13% of Aigen Investment Management's portfolio in Q2 2026, its #210 holding.
  • Aigen Investment Management first reported a position in Guardant Health in Q1 2020 and has held it in 8 quarters since.
  • Aigen Investment Management's Guardant Health position peaked at $1.21M in Q1 2025.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Aigen Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.